Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones
AssigneeBionorica AG
InventorsWolfgang Wuttke, Hubertus Jarry, Volker Christoffel, Barbara Spengler
Life of this patent
Estimating the term…
Abstract
The present invention relates to extracts from Cimicifuga species and particularly from Cimicifuga racemosa, which are suited for producing a ready-formulated drug for the selective treatment and/or prophylaxis of sexual hormone-related disorders of the uro-genital tract. The extracts in accordance with the invention are moreover suited for the treatment and/or prophylaxis of post-menopausal urinary bladder infections. They are furthermore indicated for the treatment of benign and malignant prostate hyperplasies.
Claims13
1-22. (canceled)
An estrogen-type organoselective medicament having at most a negligible uterotrophic effect, the medicament comprising an extract from a Cimicifuga species, the medicament adapted for alleviating a post-menopausally occurring urinary bladder infection when administered.
A method for alleviating a sexual hormone-related post menopausal urinary bladder infection comprising the step of administering an estrogen-type organoselective medicament to alleviate the infection, the medicament comprising an extract from a Cimicifuga species.
Dependencies are inferred from the claim text.